Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus

Background: Consistent evidence is still lacking on which one, glimepiride plus metformin or repaglinide plus metformin, is better in treating type 2 diabetes mellitus (T2DM). Therefore, this study was conducted to compare the short-term efficacy and safety of these two methods in treating T2DM. Met...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Metab Syndr Obes
Autors principals: Xie, Jing, Li, Ning, Jiang, Xiaoyan, Chai, Liyin, Chen, Jian-Jun, Deng, Wuquan
Format: Artigo
Idioma:Inglês
Publicat: Dove 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489581/
https://ncbi.nlm.nih.gov/pubmed/31114280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S198154
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars